Centre for Cellular & Molecular Biology, Indian Pharmacoepia Commission ink pact on biosimilars and herbal drugs

To facilitate regulatory process for biosimilars and herbal drugs

Updated - April 29, 2019 09:42 am IST

Published - April 29, 2019 12:10 am IST - HYDERABAD

IPC scientific director G.N. Singh with CCMB director Rakesh Mishra after signing the MoU.

IPC scientific director G.N. Singh with CCMB director Rakesh Mishra after signing the MoU.

Centre for Cellular & Molecular Biology (CCMB) has joined hands with the Ghaziabad-based Indian Pharmacoepia Commission (IPC) to facilitate regulatory process for biosimilars and herbal drugs on Sunday.

Biosimilars are biological products functioning like drugs against diseases and are rapidly making a mark in the healthcare sector across the world.

CSIR-CCMB director Rakesh Mishra and IPC Secretary G.N. Singh signed the memorandum of understanding which will come into immediate effect. Dr. Mishra said it is an important collaboration considering that there is increased usage in therapeutic proteins and herbal drugs for various diseases.

The emergence of biopharmaceutical drugs as a preferred choice for therapy over the conventional pharma drugs requires concerted efforts by various sectors towards production, characterisation and validation of indigenously developed products, he said.

The institutions will be working together on documentation and characterisation of Indian herbal drugs — phytopharmaceuticals, towards significant usage and export. The director said scientific validation and characterisation of herbal drugs will bring authenticity to the drugs and credibility to the industry as well as to the traditional knowledge.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.